NEW YORK (GenomeWeb News) – Shares of CombiMatrix closed at a 52-week high of $13.31 on Wednesday.
 
Over the past two weeks, shares of the Mukilteo, Wash.-based microarray manufacturer and molecular diagnostics firm have climbed around 20 percent. Year to date, the company’s stock is up nearly 80 percent.
 
Last week, CombiMatrix reported that its second-quarter revenues jumped 55 percent to $2.1 million, driven by diagnostic services revenue.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.